We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Low Vitamin D Levels May Harm Heart Health

By LabMedica International staff writers
Posted on 23 Nov 2015
Print article
Image: Radiograph of a child suffering a deficiency of vitamin D and has manifested symptoms of the disease Nutritional Rickets (Photo courtesy of Dr. Michael L. Richardson, MD).
Image: Radiograph of a child suffering a deficiency of vitamin D and has manifested symptoms of the disease Nutritional Rickets (Photo courtesy of Dr. Michael L. Richardson, MD).
Vitamin D is important for bone health, promoting calcium absorption, but studies have increasingly suggested the vitamin may also play an important role in heart health, linking vitamin D deficiency to increased risk for high blood pressure, heart attack and heart disease.

Individuals who do not get enough vitamin D through dietary sources including oily fish, eggs, and supplements or sun exposure often have vitamin D deficiency as when the levels of the vitamin in the body are too low, which is determined by measuring levels of 25-hydroxyvitamin D (25-OHD) in the blood.

Scientists at the Intermountain Medical Center Heart Institute (Salt Lake City, UT, USA) assessed how vitamin D levels affected the health of more than 230,000 patients who were on their database. The team allocated each patient into one of four groups dependent on their 25-OHD levels: less than 15 ng/mL, 15–29 ng/mL, 30–44 ng/mL, and more than 45 ng/mL. Over the next three years, they monitored the patients for any incidence of major cardiac events, including coronary heart disease, heart attack, stroke and heart failure, as well as incidence of kidney failure and death.

The investigators found that patients whose 25-OHD levels were less than 15 ng/mL were 35% more likely to experience a cardiovascular event in the subsequent three years than participants in the other three groups. The risk for cardiovascular events was the same for participants whose 25-OHD levels were 15–29 ng/mL, 30–44 ng/mL, or more than 45 ng/mL, according to the results. Accordingly, these findings indicate that if a person's 25-OHD levels are 15–29 ng/mL or above, they should not be concerned about the effect their vitamin D levels may have on their heart, and vitamin D supplementation is unlikely to improve heart health any further.

J. Brent Muhlestein, MD, the lead author of the study, said, “Although vitamin D levels above 30 were traditionally considered to be normal, more recently, some studies have proposed that anything above 15 was a safe level. But the numbers had not been backed up with any studies until now. Even if any level above 15 is safe, one out of 10 people still have vitamin D levels lower than that. This equates to a very large percentage of our population. The best way to determine one’s vitamin D level is by getting a blood test.” The study was presented on November 9, 2015, at the American Heart Association's Scientific Sessions held Orlando, FL, USA).

Related Links:

Intermountain Medical Center Heart Institute 


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.